OBJECTIVE: To describe the clinical manifestations, laboratory results, imaging findings, and treatments in @entity1 with @entity3807 ( @entity3807 ) seen at Mayo Clinic in Rochester, MN. @entity1 AND METHODS: In this retrospective study, we used International Classification of Diseases, Ninth Revision codes to identify all @entity1 evaluated for @entity3807 between January 1, 1996, and December 31, 2006, at Mayo Clinic in Rochester, MN. Medical records were reviewed, and clinical information was abstracted. @entity3807 was diagnosed on the basis of compatible imaging findings. @entity1 were followed up until their last visit at Mayo Clinic, @entity204 , or December 31, 2008, whichever came first. RESULTS: Of the 185 @entity1 identified as having @entity3807 , 113 (61%) were @entity1 and 72 (39%) were @entity1 . Mean    SD age at diagnosis was 57.6    11.8 years. Biopsy specimens were obtained in 142 cases (77%). The most common presenting symptoms were @entity615 (38%) and @entity490 (40%). Baseline erythrocyte sedimentation rate and/or @entity1851 levels were elevated in 88 (58%) of the 151 @entity1 tested. The median @entity1011 level at diagnosis was 1.3 mg/dL (interquartile range, 1.1-2.1 mg/dL). Fifteen @entity1 (8%) were treated with ureteral procedures only, 58 @entity1 (31%) with medications only, and 105 @entity1 (57%) with a combination of medical and surgical therapies. Seven @entity1 (4%) were not treated. Corticosteroids were initiated in 116 @entity1 (63%), and @entity440 was used in 120 @entity1 (65%). Follow-up was available for 151 @entity1 (82%). @entity1011 levels were normal at last visit in 102 (68%) of the 151 @entity1 with follow-up. No @entity1 developed @entity454 . Relapses occurred in 18 (12%) of the 151 @entity1 . Eleven @entity1 died. CONCLUSION: In this cohort, outcomes such as @entity454 or @entity204 from @entity177 were not observed. Relapses may occur, and @entity1 with @entity3807 warrant long-term follow-up.

XXXX : a retrospective review of clinical presentation, treatment, and outcomes.

@entity1 :: ('9606', 'Species') :: ['women', 'Patients', 'patients', 'PATIENTS', 'patient', 'men'] @entity440 :: ('MESH:D013629', 'Chemical') :: ['tamoxifen'] @entity454 :: ('MESH:D007676', 'Disease') :: ['end-stage renal disease'] @entity3807 :: ('MESH:D012185', 'Disease') :: ['IRF', 'Idiopathic retroperitoneal fibrosis', 'idiopathic retroperitoneal fibrosis'] @entity177 :: ('MESH:D051437', 'Disease') :: ['renal failure'] @entity615 :: ('MESH:D001416', 'Disease') :: ['back pain'] @entity490 :: ('MESH:D015746', 'Disease') :: ['abdominal pain'] @entity1011 :: ('MESH:D003404', 'Chemical') :: ['Creatinine', 'creatinine'] @entity204 :: ('MESH:D003643', 'Disease') :: ['death'] @entity1851 :: ('1401', 'Gene') :: ['C-reactive protein']
@entity3807 :: (MESH:D012185,Disease) :: ['Idiopathic retroperitoneal fibrosis']
